Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer

Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer

FromKeeping Current CME


Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer

FromKeeping Current CME

ratings:
Length:
34 minutes
Released:
May 30, 2023
Format:
Podcast episode

Description

Did you know that, if left untreated, between 30% and 50% and up to 30% of patients with C3G and IgAN, respectively, will progress to end-stage kidney disease in 10 years?    Credit available for this activity expires: 5/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992405?ecd=bdc_podcast_libsyn_mscpedu
Released:
May 30, 2023
Format:
Podcast episode

Titles in the series (100)

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.